XML 67 R12.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Inventory | 12 Months Ended
--- | ---
Dec. 31, 2016
Inventory Disclosure [Abstract] |
Inventory | Inventory The components of inventory are summarized as follows:
| As of December 31,
(In millions) | 2016 |  | 2015
Raw materials | $ | 170.4 |  |  | $ | 213.0 |
Work in process | 698.7 |  |  | 577.6 |
Finished goods | 170.3 |  |  | 143.0 |
Total inventory | $ | 1,039.4 |  |  | $ | 933.6 |
Balance Sheet Classification: |  |  |
Inventory | $ | 1,001.6 |  |  | $ | 893.4 |
Investments and other assets | 37.8 |  |  | 40.2 |
Total inventory | $ | 1,039.4 |  |  | $ | 933.6 |
Long-term inventory, which primarily consists of work in process, is included in investments and other assets in our consolidated balance sheets. As of December 31, 2015, our inventory included $24.7 million associated with our ZINBRYTA program, $24.2 million associated with our FLIXABI program and $18.4 million associated with our BENEPALI program, which had been capitalized in advance of regulatory approval. The European Commission (EC) approved the marketing authorization applications for BENEPALI and FLIXABI, two anti-tumor necrosis factor (TNF) biosimilars, for marketing in the E.U. in January 2016 and May 2016, respectively. In addition, ZINBRYTA was approved for the treatment of relapsing forms of MS in the U.S. in May 2016 and in the E.U. in July 2016. For information on our pre-approval inventory policy, please read Note 1, Summary of Significant Accounting Policies to these consolidated financial statements Inventory amounts written down as a result of excess, obsolescence, unmarketability or other reasons are charged to cost of sales, and totaled $48.2 million, $41.9 million and $50.6 million for the years ended December 31, 2016, 2015 and 2014, respectively.

X
- References No definition available. + Details
Name: | us-gaap_InventoryDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766 + Details
Name: | us-gaap_InventoryDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration